Compare Suven Life Sciences with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES SHASUN PHARMA SUVEN LIFE SCIENCES/
SHASUN PHARMA
 
P/E (TTM) x -105.1 123.9 - View Chart
P/BV x 1.6 8.5 19.3% View Chart
Dividend Yield % 1.4 0.2 597.6%  

Financials

 SUVEN LIFE SCIENCES   SHASUN PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
SHASUN PHARMA
Mar-14
SUVEN LIFE SCIENCES/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs33894 358.5%   
Low Rs16946 371.5%   
Sales per share (Unadj.) Rs52.1214.2 24.3%  
Earnings per share (Unadj.) Rs6.85.3 128.0%  
Cash flow per share (Unadj.) Rs8.615.8 54.2%  
Dividends per share (Unadj.) Rs1.501.00 150.0%  
Dividend yield (eoy) %0.61.4 41.4%  
Book value per share (Unadj.) Rs65.353.3 122.4%  
Shares outstanding (eoy) m127.2856.62 224.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.90.3 1,490.3%   
Avg P/E ratio x37.113.1 283.4%  
P/CF ratio (eoy) x29.64.4 669.6%  
Price / Book Value ratio x3.91.3 296.4%  
Dividend payout %22.018.7 117.2%   
Avg Mkt Cap Rs m32,2723,958 815.4%   
No. of employees `0001.1NA-   
Total wages/salary Rs m6612,164 30.6%   
Avg. sales/employee Rs Th6,132.2NM-  
Avg. wages/employee Rs Th611.1NM-  
Avg. net profit/employee Rs Th803.5NM-  
INCOME DATA
Net Sales Rs m6,63512,127 54.7%  
Other income Rs m242229 105.6%   
Total revenues Rs m6,87712,356 55.7%   
Gross profit Rs m1,6041,009 159.0%  
Depreciation Rs m221594 37.3%   
Interest Rs m38415 9.1%   
Profit before tax Rs m1,587230 691.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718-73 -987.3%   
Profit after tax Rs m869302 287.8%  
Gross profit margin %24.28.3 290.6%  
Effective tax rate %45.2-31.7 -142.9%   
Net profit margin %13.12.5 526.0%  
BALANCE SHEET DATA
Current assets Rs m6,2326,884 90.5%   
Current liabilities Rs m1,4908,456 17.6%   
Net working cap to sales %71.5-13.0 -551.5%  
Current ratio x4.20.8 513.7%  
Inventory Days Days8662 140.2%  
Debtors Days Days83108 76.8%  
Net fixed assets Rs m4,0434,970 81.4%   
Share capital Rs m127113 112.4%   
"Free" reserves Rs m8,1832,875 284.6%   
Net worth Rs m8,3103,020 275.1%   
Long term debt Rs m181,817 1.0%   
Total assets Rs m10,38913,347 77.8%  
Interest coverage x43.11.6 2,775.0%   
Debt to equity ratio x00.6 0.4%  
Sales to assets ratio x0.60.9 70.3%   
Return on assets %8.75.4 162.5%  
Return on equity %10.510.0 104.6%  
Return on capital %19.513.3 146.5%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m5,6225,843 96.2%   
Fx outflow Rs m1,7992,173 82.8%   
Net fx Rs m3,8223,669 104.2%   
CASH FLOW
From Operations Rs m356398 89.4%  
From Investments Rs m-279-1,635 17.0%  
From Financial Activity Rs m-2251,309 -17.2%  
Net Cashflow Rs m-14871 -208.1%  

Share Holding

Indian Promoters % 63.4 39.2 161.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.6 -  
FIIs % 0.0 17.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 39.6 92.2%  
Shareholders   37,287 20,750 179.7%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   PFIZER  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH  GSK PHARMA  

Compare SUVEN LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Apr 22, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS